Livent Stockholders vote to approve the Transaction

BRISBANE, Australia, Dec. 19, 2023 (GLOBE NEWSWIRE) — Allkem Limited (ASX and TSX: AKE, “Allkem”) refers to the proposed merger of equals between Allkem and Livent Corporation (“Livent”), (“Transaction”).

Further to Allkem’s announcement on 19 December 2023 that the requisite majorities of Allkem shareholders have voted in favour of the proposed scheme of arrangement (“Scheme”), Allkem is pleased to announce that Livent stockholders have now approved the adoption of the Transaction Agreement and the transactions contemplated by it.

The approval by Livent stockholders satisfies a key condition to implementation of the Transaction.

As announced by Allkem on 14 December 2023, the Second Court Hearing to approve the Scheme is scheduled to be held at 2:15 pm (AWST) today (Wednesday, 20 December 2023). Allkem shareholders should refer to Allkem’s ASX announcement “Allkem Shareholders vote in favour of merger with Livent” on 19 December 2023 for further information about key upcoming dates.

This release was authorised by the Board of Directors of Allkem Limited.

Allkem Limited

ABN 31 112 589 910

Level 35, 71 Eagle St
Brisbane, QLD 4000

Investor Relations & Media Enquiries

Andrew Barber
M: +61 418 783 701 E: Andrew.Barber@allkem.co

Phoebe Lee
P: +61 7 3064 3600 E: Phoebe.Lee@allkem.co

Connect

info@allkem.co
+61 7 3064 3600
www.allkem.co

           

IMPORTANT NOTICES

Not for release or distribution in the United States
This announcement has been prepared for publication in Australia and may not be released to U.S. wire services or distributed in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction, and neither this announcement or anything attached to this announcement shall form the basis of any contract or commitment. Any securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States except in transactions registered under the U.S. Securities Act of 1933 or exempt from, or not subject to, the registration of the U.S. Securities Act of 1933 and applicable U.S. state securities laws.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.